CACCURI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 7.450
AS - Asia 3.398
EU - Europa 2.698
SA - Sud America 680
Continente sconosciuto - Info sul continente non disponibili 330
AF - Africa 89
OC - Oceania 23
Totale 14.668
Nazione #
US - Stati Uniti d'America 7.300
SG - Singapore 1.261
CN - Cina 992
IT - Italia 716
BR - Brasile 564
HK - Hong Kong 430
UA - Ucraina 399
DE - Germania 304
PL - Polonia 268
VN - Vietnam 215
FI - Finlandia 208
FR - Francia 192
GB - Regno Unito 163
TR - Turchia 125
RU - Federazione Russa 121
BD - Bangladesh 99
IE - Irlanda 94
IN - India 82
CA - Canada 65
AR - Argentina 49
MX - Messico 43
SE - Svezia 42
ID - Indonesia 30
IQ - Iraq 29
BE - Belgio 28
NL - Olanda 28
ZA - Sudafrica 28
JP - Giappone 24
CZ - Repubblica Ceca 23
ES - Italia 23
AT - Austria 22
AU - Australia 22
UZ - Uzbekistan 17
CR - Costa Rica 13
EC - Ecuador 13
PK - Pakistan 13
VE - Venezuela 13
CO - Colombia 12
JO - Giordania 12
LT - Lituania 12
MA - Marocco 12
EG - Egitto 10
JM - Giamaica 10
CL - Cile 8
KE - Kenya 8
AZ - Azerbaigian 7
ET - Etiopia 7
PT - Portogallo 7
EU - Europa 6
NO - Norvegia 6
PE - Perù 6
PY - Paraguay 6
SA - Arabia Saudita 6
UY - Uruguay 6
CH - Svizzera 5
DZ - Algeria 5
IL - Israele 5
IR - Iran 5
KG - Kirghizistan 5
LB - Libano 5
MD - Moldavia 5
AE - Emirati Arabi Uniti 4
HR - Croazia 4
KZ - Kazakistan 4
LV - Lettonia 4
NG - Nigeria 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
KR - Corea 3
LK - Sri Lanka 3
MU - Mauritius 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
MY - Malesia 2
NI - Nicaragua 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
TC - Turks e Caicos 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
Totale 14.330
Città #
Fairfield 717
Ashburn 695
Singapore 671
Woodbridge 505
Hong Kong 429
San Jose 396
Seattle 354
Houston 318
Cambridge 301
Jacksonville 290
Ann Arbor 270
Warsaw 262
Chandler 256
Wilmington 240
Dallas 239
Beijing 232
Brescia 231
The Dalles 225
New York 208
Princeton 167
Los Angeles 145
Helsinki 143
Istanbul 102
Lauterbourg 98
Dublin 94
Ho Chi Minh City 78
Munich 78
Shanghai 71
Dearborn 63
Nanjing 61
Columbus 60
São Paulo 57
Chicago 52
Council Bluffs 52
Redondo Beach 50
Buffalo 49
Des Moines 49
San Francisco 49
Orem 46
Santa Clara 45
Hanoi 44
Milan 40
Moscow 36
San Diego 36
Hebei 31
London 30
Turku 30
Boardman 29
Nanchang 29
Changsha 28
Brussels 27
Rome 25
Jinan 24
Nuremberg 24
Phoenix 24
Atlanta 23
Brooklyn 22
Shenyang 22
Stockholm 22
Tianjin 22
Brno 20
Johannesburg 20
Tokyo 20
Toronto 20
Boston 19
Frankfurt am Main 19
Mexico City 19
Charlotte 18
Montreal 18
Denver 17
Guangzhou 17
Manchester 17
Chennai 15
Jiaxing 15
Rio de Janeiro 15
Tashkent 15
Amsterdam 13
Belo Horizonte 13
Curitiba 12
Dong Ket 12
San José 12
Kunming 11
Poplar 11
Romola 11
Salt Lake City 11
Baghdad 10
Porto Alegre 10
Taizhou 10
Zhengzhou 10
Amman 9
Kocaeli 9
Mumbai 9
Ningbo 9
Verona 9
Buenos Aires 8
Falkenstein 8
Haikou 8
Kilburn 8
Lallio 8
Auburn Hills 7
Totale 9.538
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 344
Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy 260
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 221
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 220
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. 220
A cluster of invasive listeriosis in Brescia, Italy. 218
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 205
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 203
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 202
A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17 198
The immunomodulatory molecule pidotimod induces the expression of the nod-like receptor nlrp12 and attenuates tlr-induced inflammation. 187
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. 186
Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing. 184
In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae. 184
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. 184
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 180
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition 175
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 172
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 172
The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions 168
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). 167
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 167
Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis. 166
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 163
Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones 162
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 160
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 160
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 160
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 160
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 159
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 154
Extensively drug-resistant Acinetobacter baumannii isolated from intensive care units in Northern Italy: a genomic approach to characterize new sequence types. 154
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 153
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 153
HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness 152
Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy 150
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 150
Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia. 150
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. 149
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 149
Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients. 147
HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis. 147
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 145
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 144
HIV-1 matrix protein p17 and its receptors. 142
Multicenter Evaluation of the Anyplex™ Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-resistant Isolates in Pulmonary and Extrapulmonary Specimens 141
HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS. 137
A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine 137
Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells 136
Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudine. 135
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient 135
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 134
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 133
Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case report 132
A topical desiccant agent in association with ultrasonic debridement in the initial treatment of chronic periodontitis: a clinical and microbiological study 131
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 130
Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae" 126
Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants 125
p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation 124
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 124
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 123
Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G 121
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 121
Programmable Nucleic Acid Nanoswitches for the Rapid, Single-Step Detection of Antibodies in Bodily Fluids 117
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 117
HIV-1 infection, microenvironment and endothelial cell dysfunction. 116
The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy 115
Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120 114
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 114
In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma 112
Role of Q675H mutation in improving SARS-CoV-2 spike interaction with the furin binding pocket 111
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 110
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 109
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 109
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study 108
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 103
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 100
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 99
Traceability of SARS-CoV-2 transmission through quasispecies analysis 98
Genomic surveillance of SARS-CoV-2 in patients presenting neurological manifestations 98
THE ROLE OF GLYCOSAMINOGLYCANS IN SPIKE SARS-CoV-2 INFECTION: FROM A MODEL FOR HEPARAN SULFATES TO A STARTING STRUCTURE FOR ANTIVIRALS 97
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 96
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants 93
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 92
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants 92
The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier 88
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of sars-cov-2 infectivity 87
Clinical Performance of OncoPredict HPV Screening Assay on Self-Collected Vaginal and Urine Specimens Within the VALHUDES Framework 86
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 86
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 84
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 80
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 80
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 79
Detection of SARS-CoV-2 Alpha variant in a severely immunocompromised HIV-1-infected patient in the omicron era 78
The role of heparin in spike SARS-COV-2 infection: From a model for heparan sulfates to a starting structure for antivirals 78
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 78
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 73
Viral proteins as emerging cancer therapeutics 69
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies 68
Virucidal efficacy of a novel silver-based disinfectant against SARS-CoV-2 Omicron BA.5 62
Totale 13.787
Categoria #
all - tutte 73.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022774 0 129 9 47 17 34 45 83 32 94 63 221
2022/2023839 121 11 28 54 77 199 4 107 142 2 52 42
2023/2024895 61 18 75 65 46 141 50 43 184 26 46 140
2024/20252.118 32 14 22 284 156 195 205 102 202 188 442 276
2025/20264.886 436 619 469 581 463 355 752 167 227 495 173 149
2026/2027212 156 56 0 0 0 0 0 0 0 0 0 0
Totale 14.668